Snowden Capital Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,660
Closed -$1.19M 1245
2024
Q1
$1.19M Buy
3,660
+1,192
+48% +$293K 0.04% 455
2023
Q4
$470K Sell
2,468
-64
-3% -$12.1K 0.02% 720
2023
Q3
$504K Sell
2,532
-515
-17% -$122K 0.02% 651
2023
Q2
$870K Buy
3,047
+12
+0.4% +$3.33K 0.03% 501
2023
Q1
$658K Buy
3,035
+43
+1% +$8.38K 0.03% 607
2022
Q4
$615K Buy
2,992
+243
+9% +$61.4K 0.03% 621
2022
Q3
$764K Buy
2,749
+920
+50% +$234K 0.03% 499
2022
Q2
$349K Buy
+1,829
New +$323K 0.02% 797

Other funds holding SWAV

Snowden Capital Advisors's SWAV Position: Q2 2024 in Review

Snowden Capital Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,660 shares — an estimated $1.19M sold.

Snowden Capital Advisors first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $1.19M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Snowden Capital Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 3,660 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.19M.
  • Snowden Capital Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Snowden Capital Advisors's Shockwave Medical, Inc. Common Stock position peaked at $1.19M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Snowden Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.